(Q46910421)

26 December 2017

title

Androgen receptor activity is inhibited in response to genotoxic agents in a p53-independent manner (English)

1 reference

26 December 2017

1 reference

Mantoni TS

1 reference

26 December 2017

Reid G

series ordinal

1 reference

26 December 2017

Garrett MD

series ordinal

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

26 December 2017

published in

Oncogene

1 reference

26 December 2017

volume

1 reference

26 December 2017

issue

1 reference

26 December 2017

page(s)

3139-3149

1 reference

26 December 2017

The p53-inhibitor pifithrin-alpha inhibits firefly luciferase activity in vivo and in vitro

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Caspases: the executioners of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Inhibition of p53 function diminishes androgen receptor-mediated signaling in prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Development of prostate cancer treatment: the good news

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Classification of anticancer drugs—a new system based on therapeutic targets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Hsp90 Regulates Androgen Receptor Hormone Binding Affinityin Vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

The development of androgen-independent prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Etoposide: four decades of development of a topoisomerase II inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Molecular mechanisms involved in cisplatin cytotoxicity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Cell-cycle checkpoints and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Early diagnosis and surgical management of prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Androgen-induced recruitment of RNA polymerase II to a nuclear receptor-p160 coactivator complex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Loss of androgen receptor transcriptional activity at the G(1)/S transition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

The p53 response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

The program of androgen-responsive genes in neoplastic prostate epithelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Radical radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Hormone resistance in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

The promoter of the prostate-specific antigen gene contains a functional androgen responsive element

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Coregulator codes of transcriptional regulation by nuclear receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

HSP90 and the chaperoning of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Phosphorylation of androgen receptor isoforms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

ATM, ATR and DNA-PK: initiators of the cellular genotoxic stress responses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209347

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209347

1 reference

26 December 2017

1 reference

26 December 2017